Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm (MPN) characterized by sustained mature neutrophilic leukocytosis. Recently, presence of colony-stimulating factor 3 receptor () mutations has been added to the diagnostic criteria for CNL. Anti-inflammatory effects of the JAK1/2 inhibitor ruxolitinib relieve constitutional symptoms associated with MPN, such as fatigue, night sweats, and fever. We present a case of CNL harboring T618I mutation exacerbated by concomitant bilateral renal abscesses, which was refractory to antibiotics, at the time of initial diagnosis. In this case, ruxolitinib rapidly improved not only CNL but the infection, due to its anti-inflammatory potency.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479014PMC
http://dx.doi.org/10.1016/j.lrr.2022.100348DOI Listing

Publication Analysis

Top Keywords

anti-inflammatory effects
8
chronic neutrophilic
8
neutrophilic leukemia
8
harboring t618i
8
t618i mutation
8
bilateral renal
8
renal abscesses
8
effects ruxolitinib
4
ruxolitinib chronic
4
leukemia harboring
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!